The Transverse Myelitis drug pipeline focuses on immunotherapies, corticosteroids, and biologics aiming to reduce inflammation and prevent neurological damage. https://www.expertmarketresearch.com/clinical-trials/transverse-myelitis-drug-pipeline-insight